Revolutionizing the Treatment of Fibrotic Disease.

Revolutionizing the Treatment of Fibrotic Disease.

Revolutionizing the Treatment of Fibrotic Disease.

Pipeline

We are positioned to build a pipeline across a range of fibrotic diseases.

Learn More

BLD-2660
(COVID-19 Lung Disease and IPF)

Phase 2a (2Q20)

BLD-0409
(NASH)

Phase 1

BLD-2184
(Neurodegeneration)

Preclinical

BLD-2736
(Anti SARS CoV2)

Preclinical

Join our team

We are looking for people with the passion and commitment of the values we live by.

Learn More

Passion and commitment to our mission

Accountability to the team

Integrity in everything we do

Be fearless

Recent News

Webcast

Bringing life changing and revolutionary treatments to patients with fibrotic diseases.